| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $477.42 | $4,535,479.91 | -2.8% | - | - | |
| Sep 28, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $480.85 | $4,568,106.27 | -2.8% | - | - | |
| Sep 28, 2026 | CGC Canopy Growth Corporation | Lazzarato David Angelo75 | Director | Sell | 22,380 | $0.93 | $20,741.78 | -10.6% | - | - | |
| Sep 28, 2026 | CGC Canopy Growth Corporation | Atkins M Shan55 | Director | Sell | 3,096 | $0.93 | $2,869.37 | -2.1% | - | - | |
| Sep 28, 2026 | CGC Canopy Growth Corporation | Bayern Joseph | Director | Sell | 3,096 | $0.93 | $2,869.37 | -2.1% | - | - | |
| Sep 28, 2026 | CGC Canopy Growth Corporation | Yanofsky Theresa75 | Director | Sell | 14,920 | $0.93 | $13,827.86 | -10.2% | - | - | |
| Sep 28, 2026 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 120,000 | $0.03 | $3,600.00 | -0.4% | - | - | |
| Sep 25, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $476.17 | $4,523,635.17 | -2.8% | - | - | |
| Sep 24, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $473.55 | $4,498,752.61 | -2.8% | - | - | |
| Sep 23, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $491.57 | $4,669,917.54 | -2.8% | - | - | |
| Sep 22, 2026 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi56 | Chief Financial Officer | Sell | 29,277 | $29.95 | $876,846.15 | -11.0% | - | - | |
| Sep 22, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $494.83 | $4,700,850.58 | -2.8% | - | - | |
| Sep 21, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $494.55 | $4,698,270.73 | -2.8% | - | - | |
| Sep 21, 2026 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 4,139 | $25.00 | $103,475.00 | -2.4% | - | - | |
| Sep 18, 2026 | TEVA Teva Pharmaceutical Industries Limited | Mignone Roberto | Director | Sell | 367,600 | $39.06 | $14,356,801.80 | -100% | - | - | |
| Sep 18, 2026 | TEVA Teva Pharmaceutical Industries Limited | Savage Brian | Interim Chief Legal Officer | Sell | 7,342 | $38.85 | $285,215.19 | -46.3% | - | - | |
| Sep 18, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $494.79 | $4,700,504.68 | -2.8% | - | - | |
| Sep 17, 2026 | CGC Canopy Growth Corporation | Stewart Thomas Carlton45 | See Remarks | Sell | 25,755 | $0.93 | $23,952.15 | -4.2% | - | - | |
| Sep 17, 2026 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi56 | Chief Financial Officer | Sell | 12,313 | $28.82 | $354,860.66 | -4.7% | - | - | |
| Sep 17, 2026 | UTHR United Therapeutics Corporation | Mahon Paul A46 | EVP &General Counsel | Sell | 8,300 | $497.54 | $4,129,607.97 | -15.5% | - | - | |
| Sep 17, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $496.06 | $4,712,580.47 | -2.8% | - | - | |
| Sep 16, 2026 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | Senior EVP, Production Center | Sell | 10,000 | $23.94 | $239,404.00 | -5.6% | - | - | |
| Sep 16, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $501.39 | $4,763,172.19 | -2.8% | - | - | |
| Sep 16, 2026 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 6,236 | $27.86 | $173,734.96 | -2.0% | - | - | |
| Sep 16, 2026 | INM Inmed Pharmaceuticals Inc. | Adar1 Capital Management, LLC78 | 10% Owner | Buy | 91,101 | $1.30 | $118,076.02 | +11.4% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.